James Miller

Acquired lipodystrophy associated with immune checkpoint inhibitors.

Subashini Gnanendran, James Miller, C. Archer, 2020, Melanoma research.

Aberrant lipid metabolism in anaplastic thyroid carcinoma reveals stearoyl CoA desaturase 1 as a novel therapeutic target.

J. Copland, R. Smallridge, L. Marlow, 2015, The Journal of clinical endocrinology and metabolism.

Soluble CD70: a novel immunotherapeutic agent for experimental glioblastoma.

M. Weller, G. Tabatabai, L. Stitz, 2010, Journal of neurosurgery.

Abstract 4459: Accelerated drug discovery platform yields synthesis of novel stearoyl-CoA desaturase 1 inhibitors that demonstrate anti-tumor efficacy in several models of aggressive cancer

Amy L. Lane, D. Radisky, J. Copland, 2015 .

Cutaneous Adverse Events of Anti-PD-1 Therapy and BRAF Inhibitors

Subashini Gnanendran, James Miller, S. Hwang, 2020, Current Treatment Options in Oncology.

Rational design and development of a peptide inhibitor for the PD-1/PD-L1 interaction.

Bo Xu, R. Boohaker, M. Suto, 2018, Cancer letters.